Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer

NCT00354224 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped due to low accrual

Conditions

Gastric Cancer

Interventions

DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

Medical University of South Carolina